J Korean Ophthalmol Soc.  1989 Apr;30(2):185-193.

Clinical evaluation of AMVISC(R) as a Vicodlastic Substance in Extracapsular Cataract Extraction with Intracoular lens Implantation

Affiliations
  • 1Department of Ophthalmology, Kangnam St. Mary's Hospital, Catholic University, Medical College, Seoul, Korea.

Abstract

The effects of AMVISC(R) and Healon(R) in patients undergoing extracapsular cataract extraction with intraocular lens implantation were compared to the operative efficiency and postoperative reactions namely, inflammation, intraocular pressure, corneal endothelial damage, and corneal thickness. During the course of the cataract operations, twenty eyes received AMVISC(R) and twenty eyes received Healon(R). The AMVISC(R) and Healon(R) were all aspirated from anterior and posterior cha mbers by means of the irrigation and aspiration system at the end of the procedure. There were no significant difference in operative efficacy and postoperative reactions between AMVISC(R) group and Healon(R) group.

Keyword

AMVISC(R); Healon(R); operative efficacy; inflammation; intraocular pressure; corneal endothelial damage; corneal thickness

MeSH Terms

Cataract Extraction*
Cataract*
Humans
Inflammation
Intraocular Pressure
Lens Implantation, Intraocular
Full Text Links
  • JKOS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr